This study assess information quality provided by pharmaceutical sales representatives to family physicians in Montreal, Vancouver, Sacramento and Toulouse. In all sites, physicians were rarely informed about serious adverse events.
This study aimed to shed light on the potential unintended consequences of the current financing arrangement for prescription drugs in Ontario. The results provide some evidence that the relatively small user charges in Ontario affect individuals’ behaviours.
A divide exists between the federal and provincial governments with regard to the availability of pharmaceutical safety and efficacy information. The study interviews drug plan officials to better understand provincial views on the Canadian drug safety system.